Literature DB >> 20839225

Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children.

Karen Huen1, Lisa Barcellos, Kenneth Beckman, Sherri Rose, Brenda Eskenazi, Nina Holland.   

Abstract

Paraoxonase 1 (PON1) prevents oxidation of low-density lipoproteins and inactivates toxic oxon derivatives of organophosphate pesticides (OPs). More than 250 SNPs have been previously identified in the PON1 gene, yet studies of PON1 genetic variation focus primarily on a few promoter SNPs (-108, -162) and coding SNPs (192, 55). We sequenced the PON1 gene in 30 subjects from a Mexican-American birth cohort and identified 94 polymorphisms with minor allele frequencies >5%, including several novel variants (six SNPs, one insertion, and two deletions). Variants of the PON1 gene and three SNPs from PON2 and PON3 were genotyped in 700 children and mothers from the same cohort. PON1 phenotype was established using two substrate-specific assays: arylesterase (AREase) and paraoxonase (POase). Twelve PON1 and two PON2 polymorphisms were significantly associated with AREase activity, and 37 polymorphisms with POase activity; however, only nine were not in strong linkage disequilibrium (LD) with either PON1(-108) or PON1(192) (r(2) > 0.20), SNPs with known effects on PON1 quantity and substrate-specific activity. Single tagSNPs PON1(55) and PON1(192) accounted for similar ranges of AREase variation compared to haplotypes comprised of multiple SNPs within their haplotype blocks. However, PON1(55) explained 11-16% of POase activity, while six SNPs in the same haplotype block explained threefold more variance (36-56%). Although LD structure in the PON cluster seems similar between Mexicans and Caucasians, allele frequencies for many polymorphisms differed strikingly. Functional effects of PON genetic variation related to susceptibility to OPs and oxidative stress also differed by age and should be considered in protecting vulnerable subpopulations.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20839225      PMCID: PMC3003760          DOI: 10.1002/em.20567

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  43 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

Review 2.  How introns influence and enhance eukaryotic gene expression.

Authors:  Hervé Le Hir; Ajit Nott; Melissa J Moore
Journal:  Trends Biochem Sci       Date:  2003-04       Impact factor: 13.807

3.  Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.

Authors:  Gail P Jarvik; Thomas S Hatsukami; Chris Carlson; Rebecca J Richter; Rachel Jampsa; Victoria H Brophy; Sadie Margolin; Mark Rieder; Deborah Nickerson; Gerard D Schellenberg; Patrick J Heagerty; Clement E Furlong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-12       Impact factor: 8.311

Review 4.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

5.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

Review 6.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

Review 7.  Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.

Authors:  Lucio G Costa; Rebecca J Richter; Wan-Fen Li; Toby Cole; Marina Guizzetti; Clement E Furlong
Journal:  Biomarkers       Date:  2003 Jan-Feb       Impact factor: 2.658

8.  Longitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypes.

Authors:  Karen Huen; Kim Harley; Asa Bradman; Brenda Eskenazi; Nina Holland
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

9.  Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.

Authors:  Sara Deakin; Ilia Leviev; Marie-Claude Brulhart-Meynet; Richard W James
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

10.  Increased influence of genetic variation on PON1 activity in neonates.

Authors:  Jia Chen; Madhu Kumar; Wendy Chan; Gertrud Berkowitz; James G Wetmur
Journal:  Environ Health Perspect       Date:  2003-08       Impact factor: 9.031

View more
  13 in total

1.  Agricultural Pesticide Management in Thailand: Situation and Population Health Risk.

Authors:  Parinya Panuwet; Wattasit Siriwong; Tippawan Prapamontol; P Barry Ryan; Nancy Fiedler; Mark G Robson; Dana Boyd Barr
Journal:  Environ Sci Policy       Date:  2012-03       Impact factor: 5.581

Review 2.  Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.

Authors:  Nina Holland; Daneida Lizarraga; Karen Huen
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

3.  Cholinesterase and paraoxonase (PON1) enzyme activities in Mexican-American mothers and children from an agricultural community.

Authors:  Veronica Gonzalez; Karen Huen; Subha Venkat; Kelly Pratt; Pin Xiang; Kim G Harley; Katherine Kogut; Celina M Trujillo; Asa Bradman; Brenda Eskenazi; Nina T Holland
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-07-04       Impact factor: 5.563

4.  Organophosphate pesticide exposure, PON1, and neurodevelopment in school-age children from the CHAMACOS study.

Authors:  Brenda Eskenazi; Katherine Kogut; Karen Huen; Kim G Harley; Maryse Bouchard; Asa Bradman; Dana Boyd-Barr; Caroline Johnson; Nina Holland
Journal:  Environ Res       Date:  2014-08-27       Impact factor: 6.498

5.  Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics.

Authors:  Kristine L Witt; Patricia G Moorman; Olga Kovalchuk; Nina Holland; Gladys Block; Paul R Andreassen
Journal:  Environ Mol Mutagen       Date:  2010 Oct-Dec       Impact factor: 3.216

6.  Associations of PON1 and genetic ancestry with obesity in early childhood.

Authors:  Karen Huen; Kim Harley; Kenneth Beckman; Brenda Eskenazi; Nina Holland
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

7.  Association of organophosphate pesticide exposure and paraoxonase with birth outcome in Mexican-American women.

Authors:  Kim G Harley; Karen Huen; Raul Aguilar Schall; Nina T Holland; Asa Bradman; Dana Boyd Barr; Brenda Eskenazi
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

8.  PON1 as a model for integration of genetic, epigenetic, and expression data on candidate susceptibility genes.

Authors:  Karen Huen; Paul Yousefi; Kelly Street; Brenda Eskenazi; Nina Holland
Journal:  Environ Epigenet       Date:  2015-09-11

9.  Expression of human paraoxonase 1 decreases superoxide levels and alters bacterial colonization in the gut of Drosophila melanogaster.

Authors:  Alejandro A Pezzulo; Emma E Hornick; Michael V Rector; Miriam Estin; Anna C Reisetter; Peter J Taft; Stephen C Butcher; A Brent Carter; J Robert Manak; David A Stoltz; Joseph Zabner
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

10.  Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study.

Authors:  Federica Rizzi; Costanza Conti; Elena Dogliotti; Annalisa Terranegra; Erika Salvi; Daniele Braga; Flavia Ricca; Sara Lupoli; Alessandra Mingione; Francesca Pivari; Caterina Brasacchio; Matteo Barcella; Martina Chittani; Francesca D'Avila; Maurizio Turiel; Monica Lazzaroni; Laura Soldati; Daniele Cusi; Cristina Barlassina
Journal:  J Transl Med       Date:  2016-06-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.